Insider Transactions in Q1 2022 at Adaptimmune Therapeutics PLC (ADAP)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 18
2022
|
Adrian Rawcliffe Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
11,096
-47.4%
|
$33,288
$3.19 P/Share
|
|
Jan 18
2022
|
Elliot Norry Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,121
-37.54%
|
$6,363
$3.19 P/Share
|
|
Jan 18
2022
|
John Lunger Chief Patient Supply Officer |
SELL
Open market or private sale
|
Direct |
4,368
-37.32%
|
$13,104
$3.19 P/Share
|
|
Jan 18
2022
|
William C Bertrand Jr Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
4,368
-37.32%
|
$13,104
$3.19 P/Share
|
|
Jan 12
2022
|
Adrian Rawcliffe Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
3,046
-47.58%
|
$9,138
$3.54 P/Share
|
|
Jan 12
2022
|
Elliot Norry Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
854
-38.18%
|
$2,562
$3.54 P/Share
|
|
Jan 12
2022
|
John Lunger Chief Patient Supply Officer |
SELL
Open market or private sale
|
Direct |
1,076
-38.09%
|
$3,228
$3.54 P/Share
|
|
Jan 12
2022
|
William C Bertrand Jr Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
2,248
-37.45%
|
$6,744
$3.54 P/Share
|
|
Jan 11
2022
|
Adrian Rawcliffe Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
14,362
-47.34%
|
$43,086
$3.56 P/Share
|
|
Jan 11
2022
|
Elliot Norry Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,770
-37.28%
|
$11,310
$3.56 P/Share
|
|
Jan 11
2022
|
John Lunger Chief Patient Supply Officer |
SELL
Open market or private sale
|
Direct |
3,770
-37.28%
|
$11,310
$3.56 P/Share
|
|
Jan 11
2022
|
William C Bertrand Jr Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
3,770
-37.28%
|
$11,310
$3.56 P/Share
|
|
Jan 04
2022
|
Adrian Rawcliffe Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
5,532
-47.27%
|
$22,128
$4.06 P/Share
|
|
Jan 04
2022
|
Elliot Norry Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
849
-37.95%
|
$3,396
$4.06 P/Share
|
|
Jan 04
2022
|
John Lunger Chief Patient Supply Officer |
SELL
Open market or private sale
|
Direct |
1,070
-37.88%
|
$4,280
$4.06 P/Share
|
|
Jan 04
2022
|
William C Bertrand Jr Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
3,490
-37.27%
|
$13,960
$4.06 P/Share
|